五洲医疗(301234) - 2024 Q1 - 季度财报

Financial Performance - The total operating revenue for Q1 2024 was ¥90,040,221.08, a decrease of 23.2% compared to ¥117,355,998.88 in the same period last year[21]. - The total operating costs for Q1 2024 were ¥80,849,921.31, down 22.4% from ¥104,154,087.68 in Q1 2023[21]. - Net profit attributable to shareholders is ¥9,884,675.60, down 23.77% year-over-year[37]. - Net profit for the first quarter was 9,884,675.60, a decrease of 23.99% compared to 12,967,646.49 in the previous year[60]. - Operating profit for the quarter was 11,957,062.17, down from 15,590,525.82 in the previous year[60]. - Basic and diluted earnings per share were both 0.1454, compared to 0.1907 in the previous year, reflecting a decline in profitability[60]. - Total comprehensive income for the quarter was 9,884,675.60, a decrease from 12,967,646.49 in the previous year[60]. Cash Flow - The net cash flow from investment activities was 9,434,158.18 CNY, compared to 148,318,107.39 CNY in the previous period, indicating a significant decrease[6]. - The cash flow from operating activities was not detailed, but the overall cash position improved significantly during the quarter[6]. - The net cash flow from operating activities for Q1 2024 was ¥32,844,785.29, significantly up from ¥14,944,036.17 in Q1 2023, representing a 119.5% increase[18]. - The company's cash and cash equivalents at the end of Q1 2024 were ¥314,533,444.66, an increase of 15.9% from ¥271,319,873.54 at the beginning of the period[15]. - The company's cash and cash equivalents decreased significantly, impacting liquidity and operational flexibility[39]. - The company recorded a significant decrease of 93.64% in net cash flow from investing activities, totaling ¥9,434,158.18, due to reduced purchases and redemptions of financial products[41]. Shareholder Information - The company reported a total of 8,141 common shareholders at the end of the reporting period[12]. - The largest shareholder, Huang Fan, holds 24.16% of the shares, amounting to 13,770,000 shares[12]. - The total equity attributable to shareholders increased to ¥759,592,473.22 from ¥749,707,797.62, showing a growth of 1.2%[21]. - The total equity attributable to shareholders increased by 1.32% to ¥759,592,473.22 at the end of the current period[37]. Investment Activities - The cash inflow from investment activities was ¥125,372,587.18, down 64.3% from ¥351,356,583.24 in the same period last year[18]. - The cash outflow from investment activities totaled 115,938,429.00 CNY, compared to 203,038,475.85 CNY in the previous period, showing a decrease in investment spending[6]. - The cash outflow for purchasing fixed assets and intangible assets was ¥13,938,429.00, a decrease of 56.3% compared to ¥31,862,535.85 in Q1 2023[18]. Liabilities and Assets - The total liabilities decreased to ¥74,028,058.80 from ¥98,470,621.61, indicating a reduction of 25.0%[21]. - The total assets at the end of the current period are ¥833,620,532.02, reflecting a decrease of 1.72% from the end of the previous year[37]. - The accounts receivable decreased to ¥67,273,730.47 from ¥92,696,934.48, reflecting a reduction of 27.5%[15]. Other Income and Expenses - Financial expenses decreased significantly by 283.48%, from 1,577,924.57 to -2,895,152.53, mainly due to increased exchange gains and interest income[53]. - Other income increased by 154.62%, from 899,793.96 to 2,291,047.37, primarily due to higher government subsidies received[53]. - Investment income dropped by 84.96%, from 2,072,546.21 to 311,723.18, mainly due to reduced returns from financial products[53]. - The company reported a significant increase in credit impairment losses by 63.65%, from 943,098.18 to 1,543,400.01, attributed to a decrease in bad debt provisions[53]. Government Subsidies - The company received government subsidies amounting to ¥1,944,750.00 during the current period[38]. Non-Recurring Gains and Losses - The company adjusted its non-recurring gains and losses for the first quarter of 2023, increasing the net amount by 275,174.42 CNY after tax[10]. - The company did not report any non-recurring gains or losses during the quarter[51]. Audit and Adjustments - The first quarter report was not audited, and there were no adjustments or restatements of prior year accounting data[49][50].